03/22/2024 8:46 AM | Merrimack Pharmaceuticals (Filer)
| Form DEFA14A | |
03/21/2024 3:48 PM | Merrimack Pharmaceuticals (Filer)
| Form 10-K/A | |
03/21/2024 3:52 PM | Merrimack Pharmaceuticals (Filer)
| Form DEF 14A | |
03/07/2024 3:39 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2024 3:42 PM | Merrimack Pharmaceuticals (Subject)
| Form 425 | |
03/07/2024 11:29 AM | BlackRock Inc. (Filed by) Merrimack Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/22/2024 3:46 PM | ADAR1 Partners, LP (Filed by) Merrimack Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/13/2024 3:22 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 1:08 PM | BlackRock Inc. (Filed by) Merrimack Pharmaceuticals (Subject)
| Form SC 13G | |
12/28/2023 3:05 PM | Andersen Eric (Reporting) Merrimack Pharmaceuticals (Issuer) Western Standard LLC (Reporting) WESTERN STANDARD PARTNERS LP (Reporting) Western Standard Partners QP, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 5:59 PM | Andersen Eric (Reporting) Merrimack Pharmaceuticals (Issuer) Western Standard LLC (Reporting) WESTERN STANDARD PARTNERS LP (Reporting) Western Standard Partners QP, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 4:09 PM | Andersen Eric (Reporting) Merrimack Pharmaceuticals (Issuer) Western Standard LLC (Reporting) WESTERN STANDARD PARTNERS LP (Reporting) Western Standard Partners QP, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 3:36 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 3:36 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 4:25 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 3:31 PM | Merrimack Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/21/2023 3:15 PM | Merrimack Pharmaceuticals (Filer)
| Form DEFA14A | |
04/21/2023 8:21 AM | Merrimack Pharmaceuticals (Filer)
| Form DEF 14A | |
04/07/2023 8:16 AM | Merrimack Pharmaceuticals (Filer)
| Form PRE 14A | |